Current Oncology

Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally distributed journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in PubMed, EMBASE (Excerpta Medica Database), Scopus, Journal Selector, Crossref, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, EBSCOhost.com Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.



The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.

Announcements

 

Meeting/Conference: Atlantic Canada Oncology Group Annual CME, Halifax, June 18-19, 2016

 

ACOG will host our 20th annual education event in Halifax on Friday afternoon and Saturday morning, June 18-19. Registration includes a lobster dinner and social event on the waterfront Friday evening.

The meeting will focus on breast cancer and a variety of other topics. Details of the program and registration are posted at acog.ca, or email edsmith@nl.rogers.com.

 
Posted: 2016-04-04
 

Journal Announcement: Current Oncology, Vol 23, Suppl 2 - Now Published!

 

Use of Cannabinoids in Cancer Care

Multimed Inc. is pleased to announce that Current Oncology has published a supplement dedicated to the use of cannabinoids in cancer care.Edited by Dr. Mark Ware, this issue brings together the work of some of the leading minds around the world who have dedicated themselves and their laboratories to understanding the role of cannabis and cannabinoids in the pathophysiology and management of cancer. This collection of papers takes us on a journey from bedside to bench and back, and provides a series of important signposts that will help to chart a path to better cancer care.

We would like to thank all of the contributing authors for their work on this special supplement. We would also like to send a special thank you to Dr. Mark Ware for his hard work and dedication in bringing this supplement to fruition.

Publication of this supplement was made possible through an unrestricted grant from Mettrum to the Canadian Consortium for the Investigation of Cannabinoids (CCIC). We sincerely thank Mettrum for their support of this project and for their ongoing commitment to research and education in cannabinoid medicine.

To view the full Table of Contents, please click here.

 
Posted: 2016-03-24 More...
 

Journal Announcement: Current Oncology, Vol 23, Suppl 1 - Now Published!

 

Original Cancer Costing Research Using Canadian Data

Multimed Inc. is pleased to announce that Current Oncology has published a supplement dedicated to cancer costing research using Canadian data. Co-edited by Dr. Nicole Mittmann (Cancer Care Ontario, Toronto, ON) and Dr. Claire de Oliveira (Centre for Addiction and Mental Health, Toronto, ON), the manuscripts in this supplement use a wide array of methods and Canadian data sources to deal with various disease sites and relevant issues in cancer care. In particular, they include studies relating to breast cancer (analysis of the cost implications of unwarranted imaging of patients, and an economic evaluation of a novel technology) and cervical cancer (estimation of utilization and costs, and use of a simulation model to evaluate cytology compared with primary human papillomavirus dna screening). Other studies focus on the estimation of drug and pathology cost avoidance in clinical trials and the cost trajectories of cancer patients over time. Finally, two studies provide an overview of the trends in costs for systemic therapy, home nursing, and hospitalizations for end-of-life care across the country.

We would like to thank all of the contributing authors for their work on this special supplement. We would also like to send a special thank you to Dr. Nicole Mittmann and Dr. Claire de Oliveira for their hard work and dedication as well as the Canadian Partnership Against Cancer for their support.

To view the full Table of Contents, please click here.

 
Posted: 2016-03-02 More...
 
More Announcements...

Vol 23, No 2 (2016)

Table of Contents

Editorial(s)

Commentary(ies)

C. Jacobs, A.A. Joy, M. Clemons, S. Mazzarello, M. Fralick
71-73
A.E. Hay, C. Rae, G.A. Fraser, R.M. Meyer, L.S. Abbott, S. Bevan, M.L. McBride, G.D.E. Cuvelier, S. McKillop, R.D. Barr
e81-e85

Original Article(s)

Biomarkers in Oncology

R. Razzak, E.L.R. Bédard, J.O. Kim, S. Gazala, L. Guo, S. Ghosh, A. Joy, T. Nijjar, E. Wong, W.H. Roa
e86-e94

Cancer Control and Prevention

F.M. Patafio, S.C. Brooks, X. Wei, Y. Peng, J. Biagi, C.M. Booth
75-80

Integrative Oncology

L. Cohen, J. Hamer, C. Helwig, K. Fergus, A. Kiss, R. Mandel, B. Dawson, A. Landsberg, K. Shein, N. Kay, E. Warner
e102-e108

Knowledge Translation

S.R. Khare, G. Batist, G. Bartlett
81-90

Medical Economics

C. Pendrith, A. Thind, G.S. Zaric, S. Sarma
e109-e115

Medical Oncology

R. Ramjeesingh, C. Orr, C.S. Bricks, W.M. Hopman, N. Hammad
e116-e122
L. Li, R. Fu, T. Zhang, X. Xie, J. Liu, J. Tao, J. Song, H. Liu, W. Zhang, W. Lu, Z. Shao
e123-e130

Radiation Oncology

M. Li, F. Zhao, X. Zhang, F. Shi, H. Zhu, A. Han, Y. Zhang, L. Kong, J. Yu
e131-e137

Surgical Oncology

C. Eskicioglu, S. Forbes, S. Tsai, V. Francescutti, A. Coates, V. Grubac, R. Sonnadara, M. Simunovic
e138-e143

Review Article(s)

Practice Guideline(s)

P. Daeninck, B. Gagnon, R. Gallagher, J.D. Henderson, Y. Shir, C. Zimmermann, B. Lapointe
96-108
L. Elit, E.B. Kennedy, A. Fyles, U. Metser
109-118

Short Communication(s)

J. Chadder, R. Dewar, L. Shack, D. Nishri, J. Niu, G. Lockwood
119-124
F. Labrèche, P. Duguay, A. Boucher, R. Arcand
e144-e149

Case Report(s)

R.U. Wahl, T. Braunschweig, A. Ghassemi, A. Rübben
e150-e153
S.I. Shakir, M. Pelmus, A. Florea, J.F. Boileau, M.C. Guiot, S. Di Maio, T.M. Muanza
e154-e157

Meeting Report(s)

J.A.H. Bell, L.G. Balneaves, M.T. Kelly, H. Richardson
125-130

Letter(s) to the Editor